Mind Medicine (MindMed) Stock Forecast for 2023 - 2025 - 2030

Updated on 05/14/2024

Stock Rating
4
Price Target
$20.00
Consensus
Outperform
Upside
136.69%
Analysts
3
Stock Rating
4
Upside
136.69%
Analysts
3
Price Target
$20.00

Mind Medicine (MindMed) Stock Forecast and Price Target

Mind Medicine (MindMed)'s stock price reaches the average target of $20.00 by 2025 as expected recently by three notable experts, there would be a potential upside of approximately 136.69% from the last closing price in May, 2024. This possible increase is based on a high estimate of $36.00 and a low estimate of $16.00.

$20.00

136.69% Upside

Buy
Buy

Mind Medicine (MindMed) Fair Value Forecast for 2023 - 2025 - 2030

Mind Medicine (MindMed)'s Price has seen growth In the last two years, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is forFair Value to grow by 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

Mind Medicine (MindMed) Revenue Forecast for 2023 - 2025 - 2030

Mind Medicine (MindMed) Dividend per Share Forecast for 2023 - 2025 - 2030

Mind Medicine (MindMed) Free Cash Flow Forecast for 2023 - 2025 - 2030

Mind Medicine (MindMed) EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Mind Medicine (MindMed)'s EBITDA has increased by 107.96%, going from $-31.89M to $-66.32M. According to 0 major analysts, Mind Medicine (MindMed)'s EBITDA will fall by 3.52% in the next year, reaching $-63.98M. Professionals believe that By 2030, Mind Medicine (MindMed)'s EBITDA will fall to $-64.18M– a 3.22% decrease from its current value.

2023 EBITDA Forecast
$-63983325.33
2024 EBITDA Forecast
$-57053931.20
2025 EBITDA Forecast
$-64921668.31
2026 EBITDA Forecast
$-65718040.78
2027 EBITDA Forecast
$-65459549.82
2028 EBITDA Forecast
$-62636061.23
2029 EBITDA Forecast
$-63406484.79
2030 EBITDA Forecast
$-64184271.00

Mind Medicine (MindMed) EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Mind Medicine (MindMed)'s EBIT has grown, increasing from $-32.44M to $-93.87M – an increase of 189.36%. In the next year, 0 analysts estimate that Mind Medicine (MindMed)'s EBIT will decrease by 17.87%, reaching $-77.09M. According to professional forecasts, in 2030, Mind Medicine (MindMed)'s EBIT will decrease by 11.75%, reaching $-82.84M.

2024 EBIT Forecast
$-77092302.00
2025 EBIT Forecast
$-85690663.42
2026 EBIT Forecast
$-80660621.47
2027 EBIT Forecast
$-85492192.70
2028 EBIT Forecast
$-82802038.37
2029 EBIT Forecast
$-83861904.46
2030 EBIT Forecast
$-82838789.23

Mind Medicine (MindMed) EPS Price Prediction Forecast for 2023 - 2025 - 2030

Mind Medicine (MindMed)'s EPS has seen growth In the last two years, going from $-2.09 to $0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is forEPS to grow by 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00